Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Role of glucagon-like peptide-2 in intestinal carcinogenesis of rodent models of cancer.

FY 2009-10

Summary
Glucagon-like peptide-2 (GLP-2) is a gut hormone that is secreted when a meal is eaten. In addition, GLP-2 regulates the growth and maintenance of cells that line the gastrointestinal tract. GLP-2 is needed for normal food digestion and absorption and also for intestinal growth. It is because of these actions that GLP-2 is currently in clinical trials for the treatment of Short Bowel Syndrome (SBS) and Crohn's disease. These digestive maladies are a growing concern for the Canadian population as well as a burden to the Canadian economy as they greatly decrease quality of life. However, since GLP-2 has growth effects in the gut, it is also necessary to examine whether it can cause colon cancer. This project, which is composed of two parts, will examine whether GLP-2 affects colon cancer in rats that have been fed with a carcinogen found in our diet. In addition, we will also examine whether GLP-2 increases colon cancer in mice with colitis. These studies will further our understanding about the role of GLP-2 in cancer, and could be relevant to patients being treated with GLP-2 and other patients who are at risk of colon cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
201018
Name
Trivedi Shivangi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Role of glucagon-like peptide-2 in intestinal carcinogenesis of rodent models of cancer.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Diet; Immunohistochemistry; In Vivo; Inflammatory Bowel Disease; Intestinal Hormones
Abstract
Glucagon-like peptide-2 (GLP-2) is a gut hormone that is secreted when a meal is eaten. In addition, GLP-2 regulates the growth and maintenance of cells that line the gastrointestinal tract. GLP-2 is needed for normal food digestion and absorption and also for intestinal growth. It is because of these actions that GLP-2 is currently in clinical trials for the treatment of Short Bowel Syndrome (SBS) and Crohn's disease. These digestive maladies are a growing concern for the Canadian population as well as a burden to the Canadian economy as they greatly decrease quality of life. However, since GLP-2 has growth effects in the gut, it is also necessary to examine whether it can cause colon cancer. This project, which is composed of two parts, will examine whether GLP-2 affects colon cancer in rats that have been fed with a carcinogen found in our diet. In addition, we will also examine whether GLP-2 increases colon cancer in mice with colitis. These studies will further our understanding about the role of GLP-2 in cancer, and could be relevant to patients being treated with GLP-2 and other patients who are at risk of colon cancer.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Trivedi, Shivangi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~